- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07946471
A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin, Hair, Nail, Gut, and Overall Health Outcomes
This is a single-group, open-label, decentralized clinical trial evaluating the effects of 6 weeks of daily Glow Shakes Premium Collagen Meal Replacement consumption on body composition, weight management, and self-reported health outcomes in 40 adults aged 18-55 years with a BMI between 25-35 kg/m².
All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily, replacing two typical meals, for 6 consecutive weeks. Assessments will be conducted at Baseline, Week 2, Week 4, and Week 6 and will include validated self-report questionnaires and body composition measurements via the Withings smart scale. All study activities are conducted remotely; products are shipped directly to participants' homes and all data are submitted digitally through the Citruslabs study platform.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Izaak Woodley
- Correo electrónico: izaakwoodley@thecollagen.co
Ubicaciones de estudio
-
-
Nevada
-
Las Vegas, Nevada, Estados Unidos, 89101
- Citruslabs
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Adults aged 18-55 years at the time of enrollment.
- BMI between 25-35 kg/m² at screening, as confirmed via participant self-report and/or Withings smart scale measurement at Baseline.
- Self-reported goals around weight management, body composition improvement, or overall health and wellness at the time of enrollment.
- Willing and able to use Glow Shakes Premium Collagen Meal Replacement as a daily meal replacement (replacing two typical meals) for 6 consecutive weeks and to complete all questionnaire assessments and Withings smart scale body composition measurements at Baseline, Week 2, Week 4, and Week 6.
- Willing to maintain current diet (except for the test product), exercise routine, and lifestyle habits for the duration of the 6-week study, without introducing any new supplements or products specifically targeting weight loss, appetite, or body composition.
- In good general health.
- Resides in the United States.
Exclusion Criteria:
- Pregnant or breastfeeding at the time of enrollment, or planning to become pregnant during the 6-week study period.
- Currently using GLP-1 receptor agonists, dual-incretin medications, prescription weight loss drugs, or any other prescription medication directly affecting appetite or body weight.
- Known allergy or intolerance to any ingredient in the Glow Shakes formulation, including milk protein, whey protein, or collagen-derived (bovine) ingredients.
- Diagnosed with a serious medical condition requiring medical nutritional management, including but not limited to Type 1 diabetes, active cancer, or severe renal or hepatic disease.
- Currently testing, or plan to in the next 6 weeks, a product for another research study.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Glow Shakes Premium Collagen Meal Replacement Arm
|
All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily (replacing two meals) for 6 weeks. Assessments will be conducted at four timepoints: Baseline, Week 2, Week 4, and Week 6. Assessments will include validated self-report questionnaires and body composition measurements via the Withings smart scale. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Body Weight
Periodo de tiempo: Baseline to Week 6
|
Change in body weight (kg) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home) |
Baseline to Week 6
|
|
Change in Body Fat Percentage
Periodo de tiempo: Baseline to Week 6
|
Change in body fat percentage (%) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home) |
Baseline to Week 6
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Self-Reported Weight Management Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported weight management scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Hunger Intensity
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported hunger intensity as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Satiety Duration
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported satiety duration as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Food Craving Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported food craving scores as assessed via the Food Cravings Questionnaire-Trait Reduced (FCQ-T-reduced) |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Skin Health Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported skin health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Hair Health Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported hair health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Nail Health Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported nail health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Gut Comfort and Digestive Symptom Score
Periodo de tiempo: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported gut comfort and digestive symptom scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Participant-Reported Product Satisfaction
Periodo de tiempo: Week 6
|
Participant-reported product satisfaction, acceptability, and tolerability as assessed via product satisfaction questionnaire |
Week 6
|
|
Participant-Reported Product Tolerability
Periodo de tiempo: Week 6
|
Participant-reported tolerability of the study product as assessed via product satisfaction questionnaire |
Week 6
|
|
Participant-Reported Overall Product Experience
Periodo de tiempo: Week 6
|
Participant-reported overall experience with the study product as assessed via product satisfaction questionnaire |
Week 6
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- THECO-22384
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .